| Table 2. Treatment data and stimulation characteristics of the IVF cycles in the 2 groups. | ||||
| All (n=60) |
Stop GnRH agonist (n=30) |
GnRH antagonist (n=30) |
p-value | |
|---|---|---|---|---|
| Duration of stimulation (day) (means±SDs) | 11.0±5.2 | 12.9±6.2 | 9.1±2.9 | 0.004 |
| Total dose of gonadotropin used (IU) (means±SDs) | 3076.8±465.1 | 3321.2±152.8 | 2832.4±541.4 | <0.001 |
| Number of follicles >13 mm on day of hCG (means±SDs) | 2.8±0.7 | 3.4±0.2 | 2.2±0.5 | <0.001 |
| Number of mature oocytes retrieved (means±SDs) | 2.3±2.5 | 3.19±2.62 | 1.34±2.12 | 0.004 |
| Number of total embryos | ||||
| (means±SD) | 2.4±1.3 | 2.6±1.6 | 2.1±0.7 | 0.124 |
| Number of TQE (means±SDs) | 1.5±1.5 | 1.62±1.67 | 1.46±1.42 | 0.691 |
| Biochemical Pregnancy Rate (%) | 6.15 | 6.32 | 5.98 | 1.000 |
| Clinical Pregnancy Rate (%) | 4.9 | 4.9 | 4.9 | 1.000 |
| Total Cancellation Rate (%) | 2 | 2 | 2 | 1.000 |
TQE: top-quality embryo; IVF: